Nature Chemical Biology 2012-11-01

Enzyme redesign guided by cancer-derived IDH1 mutations.

Zachary J Reitman, Bryan D Choi, Ivan Spasojevic, Darell D Bigner, John H Sampson, Hai Yan

Index: Nat. Chem. Biol. 8(11) , 887-9, (2012)

Full Text: HTML

Abstract

Mutations in an enzyme can result in a neomorphic catalytic activity in cancers. We applied cancer-associated mutations from isocitrate dehydrogenases to homologous residues in the active sites of homoisocitrate dehydrogenases to derive enzymes that catalyze the conversion of 2-oxoadipate to (R)-2-hydroxyadipate, a critical step for adipic acid production. Thus, we provide a prototypic example of how insights from cancer genome sequencing and functional studies can aid in enzyme redesign.

Related Compounds

  • Adipic acid
  • Oxoadipic acid

Related Articles:

HMDB: a knowledgebase for the human metabolome.

2009-01-01

[Nucleic Acids Res. 37(Database issue) , D603-10, (2009)]

Age-related reference values for urinary organic acids in a healthy Turkish pediatric population.

1994-06-01

[Clin. Chem. 40(6) , 862-6, (1994)]

Prediction of skeletal muscle and fat mass in patients with advanced cancer using a metabolomic approach.

2012-01-01

[J. Nutr. 142(1) , 14-21, (2012)]

Coformer screening using thermal analysis based on binary phase diagrams.

2014-08-01

[Pharm. Res. 31(8) , 1946-57, (2014)]

Automated screening of urine samples for carbohydrates, organic and amino acids after treatment with urease.

[J. Chromatogr. A. 562(1-2) , 125-38, (1991)]

More Articles...